| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 48.5976 | 43 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.2373 | 23 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.6047 | 44 |
| GSM780719 | Untreated after 4 days (C1_2) | 41.5556 | 11 |
| GSM780720 | Untreated after 4 days (C2_2) | 44.7292 | 26 |
| GSM780721 | Untreated after 4 days (C3_2) | 49.0851 | 45 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.3571 | 38 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 46.2314 | 33 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 41.3558 | 11 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 40.4955 | 8 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 44.1266 | 23 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 45.2402 | 28 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 37.0946 | 2 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 48.799 | 44 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 43.0242 | 18 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 50.6355 | 50 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 42.1218 | 14 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 42.8209 | 17 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 45.1271 | 28 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.7867 | 16 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 40.5394 | 8 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 46.5944 | 35 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 43.6374 | 20 |